Mesothelioma | Tumor

Overcoming a Mesothelioma Diagnosis at a Young Age

April 12th 2021, 4:00pm


Mesothelioma has been categorized as an “older persons” disease, writes a 14-year survivor. Which is why, she writes, her and her family were completely caught off-guard when she was diagnosed at 21.

FDA’s Approval of Opdivo-Yervoy for Unresectable Malignant Pleural Mesothelioma was ‘Desperately Needed’, But Questions Remain

October 20th 2020, 9:00pm


The FDA’s approval or Opdivo (nivolumab) and Yervoy (ipilimumab) for the frontline treatment of patients with unresectable malignant pleural mesothelioma was desperately needed, says a thoracic oncologist at Memorial Sloan Kettering Cancer center. However, some questions remain.

FDA Approves Opdivo-Yervoy Combo for Unresectable Malignant Pleural Mesothelioma

October 2nd 2020, 8:42pm


The Food and Drug Administration’s approval of Opdivo in combination with Yervoy for patients with unresectable malignant pleural mesothelioma marks the first new systemic therapy approved in more than 15 years in this setting.

CURE's Clinical Trial Corner: Mesothelioma Edition

November 25th 2019, 7:00pm


Here is a list of clinical trials that are currently happening within the mesothelioma space.

Friday Frontline: Cancer Updates, Research and Education on November 22, 2019

November 22nd 2019, 9:00pm


From plans to sue the School District of Philadelphia over a mesothelioma diagnosis to Dwayne “The Rock” Johnson singing for a 3-year-old with acute lymphoblastic leukemia, here’s what is making headlines in the cancer space this week.

Scientists See Potential in Cellular "Death by Iron" for Cancer Treatment

October 19th 2019, 10:00pm


The same properties that make certain cancers hard to treat may also promote their death by ferroptosis, scientists at the Sloan Kettering Institute have found.

Fighting the Uncertainty of Cancer With Self-Education

October 11th 2019, 8:00pm


A seven-year mesothelioma survivor encourages patients with cancer to be their own advocate.

The Role of Immunotherapy in Treating Mesothelioma

October 11th 2019, 1:00am


A phase 3 trial compared Keytruda versus chemotherapy for patients with advanced pretreated malignant pleural mesothelioma.

Investigational Drug Shows Response in Patients with Malignant Pleural Mesothelioma

September 20th 2019, 10:00pm


Cediranib combined with platinum-based chemotherapy helped patients live longer than placebo.

Addressing Diet and Nutrition in Patients With Mesothelioma

August 12th 2019, 10:00pm


A registered dietician discussed the importance of maintaining one’s weight while going through treatment for mesothelioma.